लोड हो रहा है...
Prediction of Serum HIV-1 Neutralization Titers After Passive Administration of VRC01
BACKGROUND: VRC01 is a human IgG1 broadly neutralizing antibody (bnAb) that binds to the HIV-1 envelope glycoprotein. It is being evaluated in two ongoing efficacy trials, the first assessment of a passively-administered bnAb for HIV-1 prevention. HVTN 104 was a Phase 1 trial of VRC01. SETTING: We m...
में बचाया:
| में प्रकाशित: | J Acquir Immune Defic Syndr |
|---|---|
| मुख्य लेखकों: | , , , , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7594341/ https://ncbi.nlm.nih.gov/pubmed/31855881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002272 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|